Premium
The utility of fluorescence in situ hybridization testing in patients clinically suspected of myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative neoplasm overlap is limited in the absence of significant morphological dysplasia
Author(s) -
Virk Harpreet,
Rana Sonia,
Kapadia Alpeshkumar B.,
Sreedharanunni Sreejesh,
Mallik Nabhajit,
Kumar Narender,
Sharma Prashant,
Naseem Shano,
Sachdeva Man Updesh Singh,
Ahluwalia Jasmina,
Das Reena,
Varma Neelam,
Malhotra Pankaj
Publication year - 2020
Publication title -
international journal of laboratory hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.705
H-Index - 55
eISSN - 1751-553X
pISSN - 1751-5521
DOI - 10.1111/ijlh.13322
Subject(s) - hematology , medicine , dysplasia , editorial board , family medicine , library science , computer science